1. D. Enria, Z. Feng, A. Fretheim, C. Ihekweazu, T. Ottersen, A. Schuchat, et al., Strengthening the evidence base for decisions on public health and social measures, Bull. W. H. O., 99 (2021), 610– 610A. https://doi.org/10.2471/BLT.21.287054
2. B. J. Cowling, S. T. Ali, T. Ng, T. K. Tsang, J. C. M. Li, M. W. Fong, et al., Impact assessment of non-pharmaceutical interventions against coronavirus disease 2019 and influenza in Hong Kong: an observational study, Lancet Public Health, 5 (2020), E279–E288. https://doi.org/10.1016/S2468-2667(20)30090-6
3. S. G. Sullivan, S. Carlson, A. C. Cheng, M. B. Chilver, D. E. Dwyer, M. Irwin, et al., Where has all the influenza gone? The impact of COVID-19 on the circulation of influenza and other respiratory viruses, Australia, March to September 2020, Eurosurveillance, 25 (2020). https://doi.org/10.2807/1560-7917.ES.2020.25.47.2001847
4. S. J. Olsen, A. K. Winn, A. P. Budd, M. M. Prill, J. Steel, C. M. Midgley, et al., Changes in influenza and other respiratory virus activity during the COVID-19 pandemic–United States, 2020–2021, Morb. Mortal. Wkly. Rep., 70 (2021), 1013–1019. https://doi.org/10.15585/mmwr.mm7029a1
5. National Institute of Infectious Diseases, Tuberculosis and Infectious Diseases Department, Health Service Bureau, Ministry of Health, Labour and Welfare. Infect. Agents Surveill. Rep. (IASR), 42 (2021), 239–270. Available from: https://www.niid.go.jp/niid/images/idsc/iasr/42/501.pdf.
6. National Institute of Infectious Diseases, Tuberculosis and Infectious Diseases Department, Health Service Bureau, Ministry of Health, Labour and Welfare. Infect. Dis. Wkly. Rep. (IDWR), 23 (2021), 29. Available from: https://www.niid.go.jp/niid/images/idsc/idwr/IDWR 2021/idwr2021-29.pdf.
7. R. E. Baker, S. W. Park, W. Yang, G. A. Vecchi, C. J. E. Metcalf, B. T. Grenfell, The impact of COVID-19 nonpharmaceutical interventions on the future dynamics of endemic infections, Proc. Natl. Acad. Sci., 117 (2020), 30547–30553. https://doi.org/10.1073/pnas.2013182117
8. L. Madaniyazi, X. Seposo, C. F. S. Ng, A. Tobias, M. Toizumi, H. Moriuchi, et al., Respiratory syncytial virus outbreaks are predicted after the COVID-19 pandemic in Tokyo, Japan, Jpn. J. Infect. Dis., 75 (2022), 209–211. https://doi.org/10.7883/yoken.JJID.2021.312
9. M. Ujiie, S. Tsuzuki, T. Nakamoto, N. Iwamoto, Resurgence of respiratory syncytial virus infections during COVID-19 pandemic, Tokyo, Japan, Emerging Infect. Dis., 27 (2021), 2969– 2970. https://doi.org/10.3201/eid2711.211565
10. A. A. Gershon, J. Breuer, J. I. Cohen, R. J. Cohrs, M. D. Gershon, D. Gilfen, et al., Varicella zoster virus infection, Nat. Rev. Dis. Primers, 1 (2015), 15016. https://doi.org/1 0.1038/nrdp.2015.16
11. WHO Vaccine-Preventable Diseases: Monitoring System 2018, World Health Organization.
12. M. Marin, M. Marti, A. Kambhampati, S. M. Jeram, J. F. Seward, Global varicella vaccine effectiveness: A meta-analysis, Pediatrics, 137 (2016), e20153741. https://doi.org/10.1542/ peds.2015-3741
13. M. E. Halloran, S. L. Cochi, T. A. Lieu, M. Wharton, L. Fehrs, Theoretical epidemiologic and morbidity effects of routine varicella immunization of preschool children in the United States, Am. J. Epidemiol., 140 (1994), 81–104. https://doi.org/10.1093/oxfordjournals.aje.a117238
14. M. Brisson, W. J. Edmunds, N. J. Gay, B. Law, G. D. Serres, Modelling the impact of immunization on the epidemiology of varicella zoster virus, Epidemiol. Infect., 125 (2000), 651– 669. https://doi.org/10.1017/S0950268800004714
15. H. F. Gidding, M. Brisson, C. R. Macintyre, M. A. Burgess, Modelling the impact of vaccination on the epidemiology of varicella zoster virus in Australia, Aust. N. Z. J. Public Health, 29 (2005), 544–551. https://doi.org/10.1111/j.1467-842X.2005.tb00248.x
16. Z. Gao, H. F. Gidding, J. G. Wood, C. R. MacIntyre, Modelling the impact of one-dose vs. two- dose vaccination regimens on the epidemiology of varicella zoster virus in Australia, Epidemiol. Infect., 138 (2010), 457–468. https://doi.org/10.1017/S0950268809990860
17. M. Karhunen, T. Leino, H. Salo, I. Davidkin, T. Kilpi, K. Auranen, Modelling the impact of varicella vaccination on varicella and zoster, Epidemiol. Infect., 138 (2010), 469–481. https://doi.org/10.1017/S0950268809990768
18. A. J. V. Hoek, A. Melegaro, E. Zagheni, W. J. Edmunds, N. Gay, Modelling the impact of a combined varicella and zoster vaccination programme on the epidemiology of varicella zoster virus in England, Vaccine, 29 (2011), 2411–2420. https://doi.org/10.1016/j.vaccine.2011.01.037
19. A. Melegaro, V. Marziano, E. D. Fava, P. Poletti, M. Tirani, C. Rizzo, et al., The impact of demographic changes, exogenous boosting and new vaccination policies on varicella and herpes zoster in Italy: A modelling and cost-effectiveness study, BMC Med., 16 (2018), 117. https://doi.org/10.1186/s12916-018-1094-7
20. J. Karsai, R. Csuma-Kovács, Á. Dánielisz, Z. Molnár, J. Dudás, T. Borsos, et al., Modeling the transmission dynamics of varicella in Hungary, J. Math. Ind., 10 (2020), 12. https://doi.org/10.1186/s13362-020-00079-z
21. J. Suh, T. Lee, J. K. Choi, J. Lee, S. H. Park, The impact of two-dose varicella vaccination on varicella and herpes zoster incidence in South Korea using a mathematical model with changing population demographics, Vaccine., 39 (2021), 2575–2583. https://doi.org/10.1016/j.vaccine.2021.03.056
22. M. Pawaskar, C. Burgess, M. Pillsbury, T. Wisløff, E. Flem, Clinical and economic impact of universal varicella vaccination in Norway: a modeling study, PLoS One, 16 (2021), e0254080. https://doi.org/10.1371/journal.pone.0254080
23. National Institute of Infectious Diseases, Tuberculosis and Infectious Diseases Department, Health Service Bureau, Ministry of Health, Labour and Welfare, Cumulative vaccination coverage report. Available from: https://www.niid.go.jp/niid/images/vaccine/cum-vaccine- coverage/cum-vaccine-coverage_30.pdf.
24. A. Suzuki, H. Nishiura, Reconstructing the transmission dynamics of varicella in Japan: An elevation of age at infection, PeerJ, 10 (2022), e12767. https://doi.org/10.7717/peerj.12767
25. Ministry of Health, Labour and Welfare of Japan. 2021a. Notification rules of infectious diseases: Chickenpox. Available from: https://www.mhlw.go.jp/bunya/kenkou/kekkaku-kansenshou11/01- 05-19.html.
26. Infectious Disease Surveillance Center, The report of national epidemiological surveillance of vaccine-preventable diseases. Available form: https://www.niid.go.jp/niid/ja/y-reports/669- yosoku-report.html.
27. T. Ozaki, Long-term clinical studies of varicella vaccine at a regional hospital in Japan and proposal for a varicella vaccination program, Vaccine, 31 (2013), 6155–6160. https://doi.org/10.1016/j.vaccine.2013.10.060
28. National Institute of Population and Social Security Research, Population projections for Japan (2017): 2016 to 2065. Available from: http://www.ipss.go.jp/pp-zenkoku/e/zenkoku_ e2017/pp29_summary.pdf.
29. P. E. Fine, J. A. Clarkson, Measles in England and Wales–I: An analysis of factors und erlying seasonal patterns, Int. J. Epidemiol., 11 (1982), 5–14. https://doi.org/10.1093/ije/1 1.1.5